The Scleral Lens Market has exhibited substantial growth, with a valuation of USD 319.78 million in 2023. Projections indicate further expansion, with expectations reaching USD 1197.36 million by 2031. This growth reflects the increasing adoption of scleral lenses for the management of various eye conditions, including keratoconus, dry eye syndrome, and corneal irregularities. With an anticipated compound annual growth rate (CAGR) of 15.8% over the forecast period from 2024 to 2031, the market is poised for significant development, driven by factors such as advancements in lens design, expanding applications in refractive surgery, and growing awareness about the benefits of scleral lenses among both patients and healthcare professionals.